The adjusted OR for receiving any treatment was 0.33 among patients living in an area where at least 20% of the population was below the poverty line.
Clifford Pukel, MD, discusses from an immunological standpoint the mysterious phenomenon of spontaneous regression.
Availability of important services and adequacy of care are among the factors explaining low numbers of patients with hematologic cancers being referred for hospice care.
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated.
The early integration of palliative care shortly after diagnosis of some incurable cancers improves both a patient's coping abilities and overall quality of life.
Despite the availability of palliative and supportive care at major cancer centers, patients may encounter barriers to accessing these services.
The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.
Continuous deep sedation (CDS) should be considered a viable option for patients with advanced cancer being cared for in a palliative setting.
Olanzapine, an antipsychotic, significantly improves nausea and vomiting in chemotherapy patients, according to results of a phase 3, randomized trial.
The median opioid rotation ratio (ORR) from the oral morphine equivalent daily dose (MEDD) to transdermal fentanyl in milligrams per day was 0.01.
Patients with advanced cancer and delirium at an acute palliative care unit (APCU) had a poorer survival rate.
Rates of inpatient palliative care consultation remain low and occur close to death irrespective of race/ethnicity.
ASCO Updates Metastatic Lung Cancer Therapy Guideline to Include Targeted Agents, Early Palliative CareAugust 31, 2015
ASCO updates the metastatic lung cancer guideline to include the early integration of palliative care for patients with stage 4 non-small cell lung cancer.
Most adolescents and young adults (AYAs) with cancer received medically intensive end-of-life (EOL) care measures.
Between 2000 and 2012, use of durable power of attorney increased significantly but no association established with end-of-life care decisions.
International experts reached consensus on the makeup of integration of oncology and palliative care.
Earlier palliative care consultation is associated with lower cost of hospital stay for patients with advanced cancer.
There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients.
Threading the cloak: palliative care education for care providers of adolescents, young adults with cancerMay 07, 2015
[Clinical Oncology in Adolescents and Young Adults] Integration of palliative care at the time of diagnosis enables a supportive partnership with the medical team.
Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation.
Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.
High-dose palliative radiotherapy (HDPRT) is efficacious and safe for the treatment of localized castration-resistant prostate cancer (CRPC).
A third of patients beginning palliative care die within a week.
Greatest risk of burnout in palliative care for younger doctors and those working more than 50 hours per week.
Palliative Care in Oncology Symposium: Limited time, support, and case management among barriers that hinder ability to provide palliative care.
Palliative Care in Oncology Symposium: Dispositional mindfulness may promote flourishing when confronting cancer.
Early Palliative Care Does Not Increase Costs in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)October 27, 2014
Palliative Care in Oncology Symposium: Palliative care for non-small cell lung cancer may not increase healthcare costs in the last 30 days of life.
Palliative Care in Oncology Symposium: Clinicians utilize six key elements, four longitudinal approaches and three specific techniques.
Palliative Care in Oncology Symposium: Clinical decision support using symptom assessment, management intervention improved lung cancer outcomes.
Palliative Care in Oncology Symposium: Newly diagnosed lung and colorectal cancer patients indicate unmet symptom management needs.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma